Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Gross Profit (2016 - 2025)

Marimed (MRMD) has disclosed Gross Profit for 15 consecutive years, with $10.5 million as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 17.02% to $10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.0 million through Dec 2025, down 7.62% year-over-year, with the annual reading at $57.9 million for FY2025, 7.56% down from the prior year.
  • Gross Profit for Q4 2025 was $10.5 million at Marimed, down from $16.4 million in the prior quarter.
  • The five-year high for Gross Profit was $19.4 million in Q2 2021, with the low at $10.5 million in Q4 2025.
  • Average Gross Profit over 5 years is $15.8 million, with a median of $16.3 million recorded in 2022.
  • The sharpest move saw Gross Profit skyrocketed 215.13% in 2021, then fell 26.92% in 2024.
  • Over 5 years, Gross Profit stood at $15.5 million in 2021, then rose by 2.08% to $15.8 million in 2022, then rose by 9.52% to $17.3 million in 2023, then decreased by 26.92% to $12.7 million in 2024, then dropped by 17.02% to $10.5 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $10.5 million, $16.4 million, and $16.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.